InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Woodhouse David J, 董事长兼首席执行官. Director active across 1 company, notably NGM Biopharmaceuticals INC. Aggregated, 5 filings have been published. History available since 18 November 2021. The latest transaction was disclosed on 16 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Woodhouse David J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
23,993 股Common StockSEC:0000950170-24-042609:0
13,032 股@ US$1.344.1% 占其流量Common StockSEC:0001415889-24-001541:0
127,200 股0Common StockSEC:0001209191-23-016396:0
12,987 股@ US$7.7043.3% 占其流量Common StockSEC:0001209191-21-071613:0
15,000 股@ US$7.5448.9% 占其流量Common StockSEC:0001209191-21-065973:0
5 条申报中的 5 条
About Woodhouse David J
David J. Woodhouse is the CEO of NGM Biopharmaceuticals Inc. He leads the company with a vision focused on innovation in the biopharmaceutical sector. His experience is essential for strategic development.
